Full-Time

Senior Manager

Lab Operations

Tr1X

Tr1X

11-50 employees

Develops cellular immunotherapies for autoimmune diseases

Compensation Overview

$146k - $165k/yr

+ Discretionary annual target bonus + Incentive stock options + 401(k) company contribution

No H1B Sponsorship

San Diego, CA, USA

In Person

Bachelor's

Category
Facilities Operations (2)
,
Required Skills
Microsoft Office
Inventory Management
Cell Biology

Get referred to Tr1X

See people who can refer or advise you

Requirements
  • Bachelor’s degree in biology, chemistry, environmental science, or a closely related scientific or technical field.
  • Minimum 7 years of experience in laboratory operations, Environmental, Health & Safety, facilities, or scientific operations in a research facility, biotechnology, pharmaceutical, chemical, or similar environment.
  • Solid knowledge of laboratory safety practices, hazardous materials, chemical hygiene, and hazardous waste management.
  • Experience conducting safety inspections, risk assessments, incident investigations, or compliance audits.
  • Strong understanding of applicable Environmental, Health & Safety regulations and standards, including Cal-OSHA, local regulatory agencies and inspections, permitting, and specialized biological laboratory hazards.
  • Experience with laboratory chemical inventory and hazardous waste management systems.
  • Experience working in immunology or cell biology laboratories with common equipment such as flow cytometers and plate readers.
  • Experience developing standard operating procedures, safety procedures, and compliance documentation.
  • Strong written and verbal communication, detail orientation, organizational, customer-service, and problem-solving skills.
  • Ability to manage multiple priorities and follow through in a fast-paced laboratory environment.
  • Proficiency with Microsoft Office and laboratory management, inventory, and compliance systems.
  • Legally authorized to work for any employer in the United States.
Responsibilities
  • Manage daily laboratory operations, including workspace readiness, supplies, equipment, facilities, and general laboratory support.
  • Develop, implement, and maintain laboratory operating procedures, policies, and standards.
  • Coordinate laboratory equipment installation, maintenance, calibration, repair, and decommissioning.
  • Maintain laboratory supplies, chemicals, consumables, and inventory levels.
  • Perform and oversee procurement activities, vendor relationships, service contracts, and maintenance schedules.
  • Establish efficient systems for laboratory organization, housekeeping, storage, labeling, and material management.
  • Support laboratory and facility moves, expansions, renovations, and projects, including relocations of company operations to new facilities.
  • Maintain laboratory documentation, records, inventories, and operational databases.
  • Identify opportunities to improve laboratory efficiency, workflow, cost control, and resource utilization.
  • Respond to facility service requests and partner with the property management company as needed.
  • Serve as a primary laboratory contact for Environmental, Health & Safety programs and requirements and serve as the company Safety Officer.
  • Promote a strong safety culture and ensure laboratory activities comply with company policies and regulatory requirements.
  • Conduct routine laboratory safety inspections and follow up on corrective actions.
  • Maintain and support laboratory-specific Environmental, Health & Safety programs, procedures, and documentation.
  • Coordinate chemical inventory management, labeling, storage, segregation, and disposal.
  • Manage hazardous waste, including proper collection, labeling, storage, and vendor coordination.
  • Coordinate safety training, onboarding, and required refresher training for laboratory personnel.
  • Support chemical hygiene, biosafety, and other applicable programs based on laboratory activities.
  • Maintain Safety Data Sheets and ensure appropriate access to chemical and hazard information.
  • Perform incident, accident, near-miss, and exposure investigations and implement corrective actions.
  • Coordinate emergency preparedness activities, including emergency response procedures, spill response, evacuation, and laboratory-specific emergency plans.
  • Ensure appropriate use, availability, inspection, and maintenance of personal protective equipment and safety equipment.
  • Partner with regulatory agencies and external consultants as needed.
  • Represent the company during regulatory inspections, audits, permitting, and compliance activities.
  • Monitor applicable federal, state, and local Environmental, Health & Safety requirements and ensure laboratory practices align with organizational policies and regulatory obligations.
  • Maintain required permits, records, inspections, training documentation, and compliance reports.
  • Conduct risk assessments and recommend appropriate engineering, administrative, and personal protective equipment controls.
  • Track corrective and preventive actions through completion.
  • Identify operational and safety risks and proactively implement mitigation strategies.
  • Lead and coach lab operations personnel and provide training, guidance, and career development opportunities.
  • Manage and oversee the procurement process, procedures, and systems for all laboratory-related purchasing.
  • Communicate operational priorities, safety concerns, and compliance requirements clearly to researchers and laboratory personnel.
Desired Qualifications
  • Direct, hands-on experience managing laboratory and facility expansion and relocations.
  • Experience in a regulated environment such as Good Manufacturing Practice, Good Laboratory Practice, International Organization for Standardization, or other quality-controlled laboratory settings.

Tr1X focuses on cellular immunotherapies for autoimmune and inflammatory diseases. Using a proprietary platform, it creates first-in-class cell therapy products that aim to rebalance the immune system and restore homeostasis, achieving long-term tolerance. The company develops and commercializes these therapies, generating revenue through partnerships, licensing, and direct sales, with a business base in La Jolla, CA. How it works: the core product is a cell therapy designed to modulate immune responses so the body reaches stable immune balance rather than ongoing suppression. This differs from many competitors by emphasizing durable immune tolerance via a proprietary platform and by pursuing partnerships and licensing to bring therapies to healthcare providers and patients. The goal is to deliver durable immune tolerance for autoimmune and inflammatory diseases through first-in-class cell therapies.

Company Size

11-50

Company Stage

Early VC

Total Funding

$125M

Headquarters

San Diego, California

Founded

2018

Get referred to Tr1X

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CIRM approved more than $60 million on June 25, 2026, supporting Tr1X programs.
  • October 14, 2025 financing added $50 million and runway into 2027.
  • ASGCT 2026 oral presentations signaled continued clinical momentum across GvHD, Crohn's, and MS.

What critics are saying

  • TRX103 and TRX319 remain unapproved; FDA efficacy scrutiny arrives before 2027.
  • Crohn's results from NCT06721962 report by January 30, 2027, or credibility slips.
  • No approved product means CIRM and venture cash fund only clinical execution.

What makes Tr1X unique

  • TRX103 delivered dose-dependent persistence and tolerogenic signals at ASGCT 2026.
  • TRX319 combines CD19 targeting with Tr1 regulation for progressive multiple sclerosis.
  • Maria Grazia Roncarolo's Tr1 platform creates off-the-shelf allogeneic regulatory T-cell products.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

401(k) Company Match

Flexible Work Hours

Stock Options

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

2%
San Diego Business Journal
Oct 27th, 2025
Tr1X Bio Secures $50M Funding

Tr1X Bio, based in San Diego, received FDA approval for IND status for TRX319, aimed at treating progressive multiple sclerosis. The company secured $50M in financing to support clinical trials for TRX319, set to begin next year. Tr1X's technology, based on research by Dr. Maria Grazia Roncarolo, uses allogeneic cells to treat autoimmune diseases. The company also advances TRX103 for graft vs. host disease and Crohn's disease, backed by an $8M CIRM grant.

GlobeNewswire
Oct 14th, 2025
Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in Additional Financing

Tr1X announced the FDA has cleared its IND application for TRX319 in progressive multiple sclerosis and a $50M financing that extends its runway into...

Clinical Trial Vanguard
Apr 7th, 2025
TR1X Awarded $8M Grant for TRX103 GvHD Trial

TR1X awarded $8M grant for TRX103 GvHD trial.

Benzinga
Apr 4th, 2025
Tr1X Awarded $8 Million Cirm Grant To Support Trx103 Phase 1/2A Clinical Trial For Graft-Versus-Host Disease

SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced "Trix"), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory diseases, today announced that the California Institute for Regenerative Medicine (CIRM) has awarded the Company an $8 million grant to support its ongoing Phase 1/2a clinical trial of TRX103, an engineered Tr1 Treg cell therapy for use in the prevention of graft-versus-host disease (GvHD) in blood cancer patients undergoing mismatched stem cell transplants. This award follows a $4 million CIRM grant received by Tr1X in early 2024 for late-stage preclinical research that helped to advance TRX103 to human trials. The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of RD at Tr1X, with patients enrolling at leading stem cell transplant centers across the country. The trial is designed to treat patients receiving a mismatched or haploidentical transplant with a one-time infusion of TRX103. The Company has reported positive initial persistence and safety data in the first two patient cohorts, with additional data anticipated to be reported in 2025

TMCnet
Apr 4th, 2025
Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease

Tr1X is developing TRX103 for the treatment of several immune and inflammatory disorders.